logo

For the Inventor, By the Inventor

West Caldwell, NJ, United States of America

Christopher Self

This inventor holds 23 USPTO granted patents and 1 EPO patent, primarily in Antibacterial Agents. Top assignees: Praecis Pharmaceuticals, Inc., Provid Pharmaceuticals Inc., Immune Control Inc.. Active years: 1999-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher Self. Retrieved from https://idiyas.com/inventor/christopher-self

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23

% Patents Active = 34.8

 

Average Co-Inventor Count = 4.9

ph-index = 7

Forward Citations = 326(Granted Patents)


Location History:

  • West Caldwell, NJ (US) (1999 - 2016)
  • Monmouth Junction, NJ (US) (2016 - 2017)

Company Filing History:

goldMedal11 out of 43 
 
Praecis Pharmaceuticals, Inc.
 patents
silverMedal6 out of 6 
 
Provid Pharmaceuticals Inc.
 patents
bronzeMedal2 out of 2 
 
Immune Control Inc.
 patents
4. 2 out of 1,496 
 
Rutgers, The State University of New Jersey
 patents
5. 2 out of 3,693 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
6. 1 out of 14 
 
Cognosci, Incorporated
 patents
7. 1 out of 5,024 
 
Hoffmann-La Roche Inc.
 patents
8. 1 out of 190 
 
Sequenom, Inc.
 patents
9. 1 out of 16,008 
 
University of California
 patents
where one patent can have more than one assignee

Years Active: 1999-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Aryl Myxopyronin Derivatives
Kinase Inhibitors
MHC Class II Molecules
Activated Lymphocytes
APO E Analogs
Melanoma Treatment
Angiogenesis Modulation
Beta-Amyloid Aggregation
Dihomo-Seco-Cholestanes
23 patents (USPTO):Explore Patents
1. 9592221 - Antibacterial agents: aryl myxopyronin derivatives (2017-03-14),
2. 9315495 - Antibacterial agents: aryl myxopyronin derivatives (2016-04-19),
3. 9278089 - Method of treating HCV infection with a small molecule CHK2 inhibitor (2016-03-08),
4. 8765802 - Kinase inhibitors, compositions thereof, and methods of use therewith (2014-07-01),
5. 8598312 - Inhibitors of antigen presentation by MHC class II molecules (2013-12-03),
6. 8222215 - Methods for the use of inhibitors of antigen presentation by MHC class II molecules (2012-07-17),
7. 7981885 - Compositions for treatment of diseases related to activated lymphocytes (2011-07-19),
8. 7947645 - APO E analogs and methods for their use (2011-05-24),
9. 7923445 - Methods for treatment of diseases related to activated lymphocytes (2011-04-12),
10. 7803774 - Modulators of β-amyloid peptide aggregation (2010-09-28),
11. 7439231 - Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof (2008-10-21),
12. 7432342 - Kinase anchor protein muteins, peptides thereof and related documents (2008-10-07),
13. 7405194 - Therapeutic agents and methods of use thereof for the treatment of melanoma (2008-07-29),
14. 7348307 - Methionine aminopeptidase-2 inhibitors and methods of use thereof (2008-03-25),
15. 7268111 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2007-09-11),

Title: The Innovative Mind of Christopher Self

Introduction: Christopher Self, a talented inventor hailing from West Caldwell, NJ, has made significant contributions to the world of technology and innovation.

Latest Patents: Christopher Self holds several patents in the field of renewable energy technologies, including a groundbreaking solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the industry, Christopher Self has worked for top renewable energy companies, leading research and development teams to create cutting-edge solutions for a sustainable future.

Collaborations: Throughout his career, Christopher Self has collaborated with renowned scientists and engineers from prestigious universities and research institutions, fostering a culture of innovation and excellence in every project.

Conclusion: Christopher Self's passion for innovation and his dedication to creating a greener world through technology make him a true pioneer in the field of renewable energy. His inventive spirit continues to inspire the next generation of inventors and engineers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…